(b)(4).Livanova usa, inc.Submits this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation, based on information that livanova has obtained, but may not have been able to investigate or verify prior to the date the report was required by the fda.This report does not constitute an admission, or a conclusion by fda or anyone else, that the device, livanova, or livanova's employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects¿ or "malfunctions¿.These words are incorporated into the fda 3500a medwatch form by the fda, and livanova objects to their use.(b)(4).
|
It was reported that patient had difficulty speaking, pain, coughing up blood, weight loss, and a seizure which caused him to be admitted to the hospital.Patient also believes that the device had caused nerve damage.The device was noted to be disabled after being admitted, and dr.Stated the device was defective and should be removed.Patient is noted to be on maximum output current.Patient was then sent to neurology center, where they had stated they will not remove his device.Patient threatened legal action against the neurology clinic due to this.The reported seizure is not deemed to be an increase and will not be captured within this report.The report of nerve damage has not been verified by a medical professional and will be encompassed under the reported pain.No known relevant surgical intervention has occurred to date.No additional or relevant information has been received to date.
|